FeesSafety
Pluang+

Prime Medicine plans $125M public offering to fund gene editing therapy development

Company Fundamentals
10 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
Prime Medicine plans $125M public offering to fund gene editing therapy development

Prime Medicine, a biotechnology company specializing in gene editing therapies, announced a proposed $125 million public offering of common stock, with an option for underwriters to purchase an additional $18.75 million. The offering aims to support the development of its proprietary Prime Editing platform, targeting diseases in liver, lung, immunology, and oncology. The final terms depend on market conditions and regulatory approval, with major banks managing the offering. This move could accelerate Prime Medicine's progress in delivering one-time curative genetic treatments.

Prime Medicine's proposed $125 million stock offering is context for readers following health stocks. For readers following health stocks, here is Pluang's market snapshot as of Nov 11, 2026 04:02 WIB: Of 150 priced health-sector US stocks, 52 rose and 97 fell. Notable movers include CTXR at USD 0.49, down 7.51%, with a typical hold time of 19 days and 99% buy orders; LQDA at USD 51.44, up 7.46%, with a 5-day hold time and balanced buy/sell orders; and TLRY at USD 2.65, down 6.84%, with a 32-day hold time and 56% sell orders.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
3 hours ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
3 hours ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
3 hours ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
5 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App